The present invention provides a vaccine pharmaceutical composition for transdermal administration which is safe,
usable as a prophylactic or therapeutic agent for
cancer or infectious diseases, and capable of safely and effectively inducing a systemic immune response. It can be administered to a human or
animal skin, the vaccine pharmaceutical composition including: a
lipopolysaccharide or its salt derived from at least one
gram-negative bacterium such as
Serratia, Lelercia, Rahnella, Acidicaldus, Acidiphilium, Acidisphaera, Acidocella, Acidomonas, Asaia, Belnapia, Craurococcus,
Gluconacetobacter,
Gluconobacter, Kozakia, Leahibacter, Muricoccus, Neoasaia, Oleomonas, Paracraurococcus, Rhodopila, Roseococcus, Rubritepida, Saccharibacter, Stella, Swaminathania, Teichococcus, Zavarzinia,
Pseudomonas,
Achromobacter, Bacillus, Methanoculleus, Methanosarcina,
Clostridium,
Micrococcus,
Flavobacterium,
Pantoea,
Acetobacter,
Zymomonas,
Xanthomonas, and
Enterobacter, as an
immunostimulant; and at least one
antigen, the vaccine pharmaceutical composition having a
mass ratio between the
immunostimulant and the
antigen, the total
mass of the
immunostimulant / the total
mass of the
antigen, of 0.002 to 500.